The New Admedus

There has never been any doubt in my mind about the science genius at Admedus, of Professors Ian Fraser [immunotherapies] and Leon Neethling [heart valve, vessel and cardiovascular repairs etc. etc.]. And of the significance of these men in changing and improving the lives of patients. Now the Company has a new, very well credentialed acting Managing Director, Wayne Paterson, a man who has an enormous amount of global experience in the healthcare industry.

Admedus is “a global healthcare company that develops, commercialises and distributes next generation medical technologies and devices”. With the new manager and through the adoption of a new business model with a sharper focus on goals, outcomes and profitability, this commercialisation of our IP is more likely to be successful and to result in Admedus becoming an important global player in the Industry.

The recent changes of the board and of management are already resulting in a change of market sentiment. It could be said that we have a new Admedus unfolding. [Have held shares in Admedus for 2-3 years].